Sept 9 (Reuters) – Teva Pharmaceutical Industries Ltd
said Friday it hoped to win U.S. approval by late 2017
or early 2018 for its version of Mylan NV’s EpiPen
device for treating severe allergic…
The post UPDATE 1-Teva says hoping to launch EpiPen-like device by 2018 in U.S. appeared first on NASDAQ.